
A
Tribute to My Friend
and
Research Colleague,
Dr. Richard L. Garrison

by Dr. John C. Lowe
August 31, 2007
It is with the deepest sadness and sense of loss that I
write this letter to Melissa Garrison and her sons and daughters. On
Tuesday, August 14, 2007, my dear friend and research colleague Richard L.
Garrison, MD died. His passing is a sorrowful event for me and many
others. It’s also tragic in that he was only fifty-two years old, and his
immense potential for further contributions to our research and clinical
work has prematurely ended.
| Dr.
Garrison came on board as a research colleague of the Fibromyalgia
Research Foundation in 1996. This was when we conducted our three
controlled, blinded studies showing that my treatment approach,
metabolic rehabilitation, could free fibromyalgia patients from their
symptoms. |
Richard L. Garrison, MD
San Jacinto Methodist Hospital, Family Practice
Residency Training Program; Baylor College of Medicine, Department of
Family and Community Medicine, Baytown, Texas |

From then on, my friend and collaborator Jackie Yellin and Dr. Garrison
and I made up the creative, analytical, and interpretative group behind
the work that most people identify with my name. Of course, others have
contributed in more minor ways. For example, some doctors have functioned
as technicians, doing tests, and providing Jackie, Dr. Garrison, and me
with the scores to analyze and interpret. And Dr. Garrison generously lent
his brilliant mind to help solve complex problems in analyzing and
interpreting our data.
In our 1996-1997 studies, Dr. Garrison persuaded Baylor College of
Medicine, where he was a faculty member, to collaborate with us in several
ways. He got the College to contribute a research methodologist to make
sure our study design was sound, and he arranged for a professional
statistician to double-check Jackie’s and my statistics. He also arranged
for our research subjects, without cost to our foundation or research
patients, to undergo bone densitometry as part of the studies.
Through frequent and long telephone conversations, Dr. Garrison helped
Jackie and me ensure that our recent metabolic studies were
methodologically sound. In these two studies, we compared the resting
metabolic rates of fibromyalgia patients to those of healthy controls,
finding that patients had significantly lower rates. He and I had long
talks discussing proper statistical tests, their interpretation, and the
meaning of the study outcomes to metabolic rehab.
I certainly appreciate the minor help of others involved in these
studies. But I can’t find the words to express my gratitude for the
intellectual help Dr. Garrison gave Jackie and me. His intense and
incisive brainwork helped us to make the quality of these studies as high
as possible.
For a while during the 1990s, Dr. Garrison and I cotreated fibromyalgia
patients. When he transferred to the University of Texas Health Sciences
Center, he successfully treated hundreds more. When I left Houston in late
1997, the brilliant chiropractic physician Dr. Paul Breeding took over
local collaboration with Dr. Garrison. Together, they continued to help
patient-after-patient recover, and coauthored a paper for Medical
Hypotheses on fibromyalgia and thyroid hormone resistance.
Dr. Garrison was one of the smartest and most courageous physicians I
have ever known. He took hard hits for his brave stance that we were
right: that too little thyroid hormone regulation is the basis of most
patients’ fibromyalgia. The hardest hits came from physicians who promoted
the pseudo-scientific and quack notion that fibromyalgia is a psychiatric
disorder. But he stood his ground and absorbed the political blows. His
courage in the face of damaging political opposition in medicine was like
that of my old friend Robert S. Mendelsohn, MD. He, too, is now deceased,
but he directly took on conventional medicine in the 1980s. In doing so,
he was almost single-handedly responsible for the justified contempt today
of millions of people for the harm done by conventional medicine. He, like
Dr. Garrison, risked his personal career for the sake of truth and
protecting patients.
Dr. Garrison and I didn’t agree on all matters. But our friendship was
bound by a love of quality scientific work and the mission of freeing
fibromyalgia and hypothyroid patients from the misery imposed on them by
the false beliefs of conventional medicine. He and I sometimes went a year
or so without talking, but then one of us finally would contact the other,
driven by some exciting development related to the line of research he and
I had long been engrossed in.
We disagreed over some tentative conclusions, especially about some
possible contributions to and mechanisms of fibromyalgia. But this didn’t
drive us apart as friends or research colleagues; instead, our
disagreements brought us closer together. His brilliant challenging of my
own conjectures stimulated my thinking, in stark contrast to the fruitless
minds of most other fibromyalgia researchers.
Dr. Garrison’s fertile mind made him a prolific hypothesizer, as am I,
and this inevitably carried us, at least for a time, in different
intellectual and research directions. But our differences didn’t weaken
the bond I had with him, nor, I hope, the bond he felt with me. Our
differences, arising from discussions of theoretical and experimental
science, enriched both his and my mind.
I’ve spent the last two weeks in deep sorrow over the loss of Dr.
Garrison, and I don’t expect my sorrow to wane with time. I don’t yet know
the cost to Jackie’s and my research of not having Richard to collaborate
with. But whatever the cost, it’s already been compensated by the immense
contributions he made during the time he was with us.
What can one finally say upon losing so prematurely such an
extraordinary friend and colleague? I can only borrow words from Dr.
Garrison’s and my friend Dr. Paul Breeding: I’ll miss you, brother.
Thank
You For Your Continuing
Support of Our Research
|